JPRN-UMIN000008110招募中未知
Aprepitant, Palonosetron and Dexamethasone Antiemetic Therapy Evaluation trial in germ cell tumor (APDATE) - Antiemetic therapy in germ cell tumor
Department of Urology, Sapporo Medical University School of Medicine0 个研究点目标入组 30 人开始时间: 2012年6月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Uncontrollable complications 2. Brain metastasis 3. Active convulsive disease 4. Plural effusion or ascites requiring puncture 5. Obstruction of the gastric outlet or ileus 6. Vomiting or severe nausea before the chemotherapy 7. Anaphylaxis against 5-HT3 receptor inhibitors, aprepitant or dexamethasone 8. Disapproval of contraception 9. History og aprepitant or palonostron 10. Participation of other clinical trials of antiemetics
研究者
相似试验
已完成
2 期
Study of Aprepitant / Palonosetron / Dexamethasone for nausea and vomiting induced chemotherapy for breast cancer.Breast cancerJPRN-UMIN000004025Saitama Breast Cancer Clinical Study Group(SBCCSG)55
已完成
2 期
Palonosetron+Aprepitant+Dexamethasone for highly emetic chemotherapy induced nausea and voimitingJPRN-UMIN000004865iigata Lung Cancer Treatment Group95
招募中
2 期
Palonosetoron+Aprepitant+Dexamethasone Therapy in patients receiving moderately emetogenic anticancer drugs (EJCG-1001)ung cancerJPRN-UMIN000006498East Japan Chesters Group (EJCG)90
已完成
2 期
Palonosetron+Aprepitant+Dexamethasone for moderately emetic chemotherapy induced nausea and voimiting-Phase II studyung cancerJPRN-UMIN000004936iigata Lung Cancer Treatment Group160
已完成
不适用
comparision between Aprepitant and Dexamethasone For Preventing Postoperative Nausea And Vomiting In Breast Cancer PatientsCTRI/2014/12/005333AIIMS160